课题基金 / 基金详情

Analysis of von Hippil-Lindau (VHL) gene in Human Renal Cancer

Analysis of von Hippil-Lindau (VHL) gene in Human Renal Cancer
人肾癌中 von Hippil-Lindau (VHL) 基因的分析
批准号:
14571503
负责人:
KASAHARA Kotaro
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mutation of the von Hippel-Lindau (VHL) gene is responsible for familial and sporadic renal cell carcinomas as well as for cancers in many other organs. According to recent studies, the VHL protein (pVHL) is a multifunctional tumor suppressor protein associated with the inhibition of angiogenesis, cell cycle exit, fibronectin matrix assembly, and proteolysis. To examine whether pVHL affects other important cellular events such as morphogenesis, adhision, cytoskeletal organization, or motility, we introduced the VHL gene into human kidney and lung cancer cells and compared its effects with those in parental cells. Compared with non-pVHL-expressing cells, the morphogenesis of pVHL-expressing cells was remarkably changed, with cells having many focal adhesions and stress fibers and a spreading morphology. The attachment ability of non-pVHL-expressing cells was significantly increased by expression of pVHL. Additional studies showed that vinculin was translocalized from the cytoplasm to the cell membrane by the pVHL expression, indicating induction of focal adhesion formation by pVHL. Furhtermore, motility of the pVHL-expressing cells was significantly reduced compared with that of non-pVHL-expressing cells (P<0.05). These results indicate that pVHL stabilized actin organization and inhibited cell motility through focal adhesion formation. Thus, pVHL plays a crucial rold in cytoskeletal organization and motility and functions as a unique suppressor protein in malignant cells.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Recent advances in ideas on the molecular pathology and clinical aspects of Von Hippel-Lindau disease.
冯·希佩尔-林道病的分子病理学和临床方面的最新进展。
DOI: --
发表时间: 2004
期刊: Int J Clin Oncol 9・(4)
影响因子: --
作者: [Guo H, Takahashi S, Cho S, Hera T, Tomiyasu S, Sumikawa K, Tokinaga K, Ishimura H, Takahashi T, Shuin T]
通讯作者: Shuin T
The prognostic value of angiogenesis and metastasi-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter.
血管生成和转移相关基因对肾盂和输尿管移行细胞癌进展的预后价值。
DOI: --
发表时间: 2002
期刊: Clin Cancer Res. 8(6)
影响因子: --
作者: [Inoue K, Kamada M, Slaton JW, Fukata S, Yoshikawa C, Tamboli P, Dinney CP, Shuin T.]
通讯作者: Shuin T.
Hypermethylation of the PASSFIA tumor suppressor gene in Japanese clear cell renal cell carcinoma
日本透明细胞肾细胞癌中 PASSFIA 抑癌基因的高甲基化
DOI: --
发表时间: 2004
期刊: Oncol Rep. 12
影响因子: --
作者: [Tokinaka K]
通讯作者: Tokinaka K
Recent advance in ideas on the molecular pathology and Clinical aspects of vonHippel-Lindau disease
冯希佩尔-林道病分子病理学和临床方面的最新进展
DOI: --
发表时间: 2004
期刊: Int J Clin Oncol. 9
影响因子: --
作者: [Shuin T]
通讯作者: Shuin T
10
    国内基金
    海外基金
    PHD2/VHL-HIF-1α介导的糖酵解调控巨噬细胞极化抗溃疡性结肠炎的作用机制及芍药汤的影响
    VHL在膀胱癌中抑制POLD1介导的糖酵解和同源重组修复
    • 批准号:
      QN25H160106
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      王烨金鹏
    • 依托单位:
    三阴乳腺癌肿瘤干样细胞中“TNNT1-VHL-FASN”轴促进棕榈酸生成抑制CD8+T细胞杀伤功能介导免疫治疗耐药的机制研究
    • 批准号:
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      雷博
    • 依托单位:
    三阴乳腺癌肿瘤干样细胞中"TNT1-VHL-FASN"轴促进棕榈酸生成抑制CD8+T细胞杀伤功能介导免疫治疗耐药的机制研究